Logo image of EPWK

EPWK HOLDINGS LTD-A (EPWK) Stock Fundamental Analysis

NASDAQ:EPWK - Nasdaq - KYG309051061 - Common Stock - Currency: USD

10.26  +1.3 (+14.57%)

After market: 9.95 -0.31 (-3.02%)

Fundamental Rating

1

Overall EPWK gets a fundamental rating of 1 out of 10. We evaluated EPWK against 96 industry peers in the Media industry. EPWK has a bad profitability rating. Also its financial health evaluation is rather negative. EPWK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year EPWK has reported negative net income.
EPWK had a negative operating cash flow in the past year.
EPWK Yearly Net Income VS EBIT VS OCF VS FCFEPWK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

EPWK has a Return On Assets of -26.66%. This is in the lower half of the industry: EPWK underperforms 79.17% of its industry peers.
Industry RankSector Rank
ROA -26.66%
ROE N/A
ROIC N/A
ROA(3y)-29.31%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EPWK Yearly ROA, ROE, ROICEPWK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

EPWK's Gross Margin of 18.69% is on the low side compared to the rest of the industry. EPWK is outperformed by 73.96% of its industry peers.
EPWK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EPWK Yearly Profit, Operating, Gross MarginsEPWK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40

2

2. Health

2.1 Basic Checks

EPWK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EPWK remains at a similar level compared to 1 year ago.
Compared to 1 year ago, EPWK has a worse debt to assets ratio.
EPWK Yearly Shares OutstandingEPWK Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
EPWK Yearly Total Debt VS Total AssetsEPWK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M

2.2 Solvency

An Altman-Z score of 5.46 indicates that EPWK is not in any danger for bankruptcy at the moment.
EPWK has a Altman-Z score of 5.46. This is amongst the best in the industry. EPWK outperforms 88.54% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 5.46
ROIC/WACCN/A
WACC7.48%
EPWK Yearly LT Debt VS Equity VS FCFEPWK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -2M -4M -6M

2.3 Liquidity

A Current Ratio of 0.12 indicates that EPWK may have some problems paying its short term obligations.
EPWK has a Current ratio of 0.12. This is amonst the worse of the industry: EPWK underperforms 90.63% of its industry peers.
EPWK has a Quick Ratio of 0.12. This is a bad value and indicates that EPWK is not financially healthy enough and could expect problems in meeting its short term obligations.
EPWK has a worse Quick ratio (0.12) than 90.63% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
EPWK Yearly Current Assets VS Current LiabilitesEPWK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

0

3. Growth

3.1 Past

EPWK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.36%.
The Revenue has been growing slightly by 2.09% in the past year.
EPS 1Y (TTM)-11.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.36%
Revenue 1Y (TTM)2.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPWK Yearly Revenue VS EstimatesEPWK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M 20M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EPWK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EPWK Price Earnings VS Forward Price EarningsEPWK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EPWK Per share dataEPWK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EPWK!.
Industry RankSector Rank
Dividend Yield N/A

EPWK HOLDINGS LTD-A

NASDAQ:EPWK (5/23/2025, 8:00:01 PM)

After market: 9.95 -0.31 (-3.02%)

10.26

+1.3 (+14.57%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.26%
Ins Owner ChangeN/A
Market Cap229.00M
AnalystsN/A
Price TargetN/A
Short Float %5.44%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.33
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.91
BVpS-0.32
TBVpS-0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.66%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.69%
FCFM N/A
ROA(3y)-29.31%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover4.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.54%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z 5.46
F-Score2
WACC7.48%
ROIC/WACCN/A
Cap/Depr(3y)22.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.02%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.39%
OCF growth 3YN/A
OCF growth 5YN/A